QualityStocksNewsBreak – EMA Committee for Orphan Medicinal Products Recommends Designation for Catalyst Biosciences, Inc.’s (NASDAQ: CBIO) Factor IX
Shares of Catalyst Biosciences (NASDAQ: CBIO) are 15% higher this morning on news that a positive opinion recommending orphan medicinal…